跳至主要内容
临床试验/NCT01113606
NCT01113606已完成4 期

A Double-Blind, Randomized, Controlled Trial to Assess the Effects of the Obagi Nu-Derm System on Re-Epithelialization After Chemical Peel or Ablative Laser Resurfacing.

The Plastic Surgery Foundation17 个研究点 分布在 1 个国家开始时间: 2010年4月30日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
试验地点
17

研究概览

简要总结

The aims of the Skin Product Assessment Research study were to (1) develop an infrastructure and process for industry-sponsored, Plastic Surgery Educational Foundation (PSEF) research in facial aesthetic surgery and (2) test the research process by comparing outcomes of the Obagi Nu-Derm System (ODNS) and conventional therapy as treatment adjuncts in ablative facial resurfacing.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • patients with moderate to severe photo damage and rhytids, undergoing full or partial face resurfacing with chemical peel or ablative laser.
  • Fitzpatrick I-IV skin types

排除标准

  • patients unable to complete the regimen or who had used topical prescription steroids, retinoids, depigmentation products or other products containing hydroquinone and polyhydroxy acids within 8 weeks of enrollment.

研究者

发起方
The Plastic Surgery Foundation
申办方类型
Other

研究点 (17)

Loading locations...

相似试验